Company Filing History:
Years Active: 2008
Title: Yihuan Xu: Innovator in Osteoporosis Treatment
Introduction
Yihuan Xu is a notable inventor based in Newark, DE (US). He has made significant contributions to the field of medicine, particularly in the treatment of osteoporosis and autoimmune diseases. His innovative approach utilizes astrogorgiadiol, a compound that has shown promise in downregulating mRNA encoding osteopontin.
Latest Patents
Yihuan Xu holds a patent for the invention titled "Treatment of osteoporosis and autoimmune disease with astrogorgiadiol." This patent outlines methods for downregulating mRNA encoding osteopontin by administering an effective amount of astrogorgiadiol to a cell or mammal. The invention also details methods for treating osteoporosis and autoimmune diseases by providing a therapeutically effective amount of astrogorgiadiol to patients in need. Additionally, the patent includes pharmaceutical compositions that comprise astrogorgiadiol along with a pharmaceutically acceptable carrier or diluent. He has 1 patent to his name.
Career Highlights
Yihuan Xu is affiliated with the University of Delaware, where he continues to advance research in his field. His work has the potential to impact the treatment of various conditions related to bone health and immune response.
Collaborations
Some of his notable coworkers include Douglass F Taber and Mary C Farach-Carson, who have contributed to his research endeavors.
Conclusion
Yihuan Xu's innovative work in the treatment of osteoporosis and autoimmune diseases highlights the importance of research in developing effective therapies. His contributions to the field are paving the way for future advancements in medical treatments.